Jorge A. Agudelo-Pena

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Peripheral blood mononuclear cell (PBMC)- based functional evaluation of human T cell response to suppressive cells and immune-oncology therapeutics.

Peripheral blood mononuclear cell (PBMC)- based functional evaluation of human T cell response to suppressive cells and immune-oncology therapeutics.

Journal: Methods in cell biology
Published: January 31, 2026

Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy.

Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy.

Journal: Molecular therapy. Oncology
Published: December 15, 2025

Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy.

Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy.

Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025

Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy.

Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy.

Journal: Life sciences
Published: April 11, 2025

Aryl hydrocarbon receptor-ligand hexachlorobenzene promotes immunosuppression leading to mammary tumor growth and metastasis in a HER2-positive syngeneic mouse model.

Aryl hydrocarbon receptor-ligand hexachlorobenzene promotes immunosuppression leading to mammary tumor growth and metastasis in a HER2-positive syngeneic mouse model.

Journal: Environmental toxicology and pharmacology
Published: March 10, 2025

Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition.

Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition.

Journal: Biology
Published: February 07, 2025

Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model.

Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model.

Journal: Vaccine
Published: September 16, 2024

Epigenetic Reprogramming of Autophagy Leads to Uncovering a Novel Therapeutic Target for Mutant IDH1 Astrocytomas.

Epigenetic Reprogramming of Autophagy Leads to Uncovering a Novel Therapeutic Target for Mutant IDH1 Astrocytomas.

Journal: bioRxiv : the preprint server for biology
Published: April 01, 2024

Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer.

Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer.

Journal: Viruses
Published: July 24, 2023

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells.

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells.

Journal: Cancers
Published: July 04, 2023

GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.

GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.

Journal: Cancer immunology, immunotherapy : CII
Published: June 15, 2023

Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer.

Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer.

Journal: Viruses
Published: December 24, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026